Immunocore to Present Phase 1 Brenetafusp Combination Data at SITC
Immunocore says it will present Phase 1 data for brenetafusp plus KIMMTRAK in metastatic uveal melanoma at a late-breaking oral session during the 2026 SITC meeting.
Related stories
India's Trent shares rise 6.34% as fashion sales and margins improve
Trent shares rose 6.34% to 3,041.10 rupees on Friday after the apparel retailer reported higher second-quarter profit, improving existing-store sales and stronger margins.
M impact | EQUITY | Oct 30, 2026, 03:48 AM UTC
Borosil shares rise 7% after quarterly profit increase
Borosil Ltd shares are up 7% after quarterly profit rose.
M impact | EQUITY | Oct 30, 2026, 03:47 AM UTC
Steamhouse India shares fall 7.82% in pre-open trade
Shares fell 7.82% in pre-open trading after quarterly results.
M impact | EQUITY | Oct 30, 2026, 03:43 AM UTC
Garware Technical Fibres shares rise 4.42% in pre-open trade
Garware Technical Fibres shares are up 4.42% in pre-open trade on a quarterly profit jump.
M impact | EQUITY | Oct 30, 2026, 03:42 AM UTC
SKAI Worldwide Cuts Conversion Price to KRW 1,880 From KRW 2,685
SKAI Worldwide reduced its conversion price to KRW 1,880 from KRW 2,685.
L impact | EQUITY | Oct 30, 2026, 03:42 AM UTC
Vedanta Power Shares Rise 8% in Pre-Open Trade After Q2 Profit
M impact | EQUITY | Oct 30, 2026, 03:42 AM UTC